Articles by
-
CDC Recommends Other COVID-19 Vaccines Be Preferred Over Janssen/J&J
Based on concerns about the increased incidence of thrombosis with thrombocytopenia (TTS) in people who received the Janssen/Johnson…
-
FDA Approves New Combo Long-acting Monoclonal Antibodies for Pre-exposure Prevention
The FDA issued an emergency use authorization (EUA) for tixagevimab co-packaged with cilgavimab (Evusheld), administered together, for pre-exposure…
-
Vaginal Gel Approved for Bacterial Vaginosis
The FDA approved clindamycin phosphate vaginal gel, 2% (Xaciato), for the treatment of bacterial vaginosis in females 12…
-
FDA Approves Three-Antigen Hepatitis B Vaccine
The FDA approved a new hepatitis B vaccine [recombinant]) (PreHevbrio) for the prevention of infection caused by all…
-
First Liquid Topiramate Formulation Approved for Seizure Indication
The FDA has approved the first ready-to-use liquid formulation of topiramate (Eprontia oral solution) for partial-onset, primary generalized…
-
Younger Patients Now Indicated for Asthma Drug
The FDA expanded the approved indications for dupilumab (Dupixent) injection to include add-on maintenance treatment of patients 6…
-
Gender Diverse Individuals and Clinical Preventive Services: Addressing Access to Treatment and Healthcare Experiences of LGBTQIA+ People
With more than 11 million individuals in the United States identifying as LGBTQIA+ (lesbian, gay, bisexual, transgender, queer,…
-
FDA Expands Eligibility for COVID-19 Boosters to All Adult
The FDA amended the emergency use authorization (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines authorizing use…
-
CDC Recommends Pfizer COVID-19 Vaccine for Children 5 to 11 Years
CDC Director Rochelle Walensky, MD, MPH, officially endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation that…
-
Pneumococcal Vax Guideline Update
ACIP voted in favor of updates to the pneumococcal vaccination recommendations that (1) adults 65 years of age…
-
Pfizer Seeks Emergency Use Authorization for COVID-19 Oral Antiviral
Pfizer is seeking emergency use authorization (EUA) for its investigational COVID-19 oral antiviral PF-07321332/ritonavir (Paxlovid) for the treatment…
-
Hepatitis B Virus/Ebola/Smallpox, Monkeypox
In another ACIP meeting, the group unanimously voted to recommend universal hepatitis B virus (HBV) immunization in all…
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.